An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer

• Main Authors: Bible, Keith C, Menefee, Michael E, Lin, Chia-Chi Josh, Millward, Michael J, Maples, William J, Goh, Boon Cher, Karlin, Nina J, Kane, Madeleine A, Adkins, Douglas R, Molina, Julian R, Donehower, Ross C, Lim, Wan-Teck, Flynn, Patrick J, Richardson, Ronald L, Traynor, Anne M, Rubin, Joseph, LoRusso, Patricia M, Smallridge, Robert C, Burton, Jill K, Suman, Vera J, Kumar, Aditi, Voss, Jessie S, Rumilla, Kandalaria M, Kipp, Benjamin R, Chintakuntlawar, Ashish, Harris, Pamela, Erlichman, Charles
• Other Authors: MEDICINE
• Format: Article
• Language: English
• Published: MARY ANN LIEBERT, INC 2024
• Subjects: Science & Technology; Life Sciences & Biomedicine; Endocrinology & Metabolism; pazopanib; radioactive iodine refractory; differentiated thyroid cancer; kinase inhibitor; DOUBLE-BLIND; SUNITINIB; CARCINOMA; MACROCYTOSIS; TRIAL
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/248918
• Institution: National University of Singapore

10.1089/thy.2019.0269